Industry Looks To FDA’s New Combo Products Chief For Answers
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Combination Products says it is getting back on track with new leadership in place after months of flux. Industry meanwhile is pushing the office to accelerate the release of rules and guidelines to help companies navigate the relatively new area of regulation
You may also be interested in...
Combo Product Firms Lose Patience As Regs, Guidance Are Delayed Again
Combination product companies want the next FDA commissioner to raise the profile of combo product issues within the agency
Combo Product Firms Lose Patience As Regs, Guidance Are Delayed Again
Industry firms especially eager to see proposed GMP and adverse event reporting rules.
Combo Product Firms Lose Patience As Regs, Guidance Are Delayed Again
Combination product companies want the next FDA commissioner to raise the profile of combo product issues within the agency